Global Brompheniramine Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Brompheniramine will have significant change from previous year. By the most conservative estimates of global Brompheniramine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Brompheniramine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Brompheniramine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Brompheniramine, covering the supply chain analysis, impact assessment to the Brompheniramine market size growth rate in several scenarios, and the measures to be undertaken by Brompheniramine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral Solution
Tablet
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Endo International
AMAG Pharmaceuticals
USL Pharma
Watson Laboratories
PAI
Newtron Pharmaceuticals
Teva
Nexgen Pharma
Ivax Pharmaceuticals
Novartis
Tanta Pharmaceuticals
Merck
Eon Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Brompheniramine consumption (value & volume) by key regions/countries, type and access channel, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Brompheniramine market by identifying its various subsegments.
Focuses on the key global Brompheniramine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Brompheniramine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Brompheniramine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Brompheniramine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Brompheniramine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brompheniramine Consumption 2015-2025
2.1.2 Brompheniramine Consumption CAGR by Region
2.2 Brompheniramine Segment by Type
2.2.1 Oral Solution
2.2.2 Tablet
2.3 Brompheniramine Consumption by Type
2.3.1 Global Brompheniramine Consumption Market Share by Type (2015-2020)
2.3.2 Global Brompheniramine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Brompheniramine Sale Price by Type (2015-2020)
2.4 Brompheniramine Segment by Access Channel
2.4.1 Hospital
2.4.2 Drug Store
2.5 Brompheniramine Consumption by Access Channel
2.5.1 Global Brompheniramine Consumption Market Share by Type (2015-2020)
2.5.2 Global Brompheniramine Value and Market Share by Type (2015-2020)
2.5.3 Global Brompheniramine Sale Price by Type (2015-2020)
3 Global Brompheniramine by Company
3.1 Global Brompheniramine Sales Market Share by Company
3.1.1 Global Brompheniramine Sales by Company (2018-2020)
3.1.2 Global Brompheniramine Sales Market Share by Company (2018-2020)
3.2 Global Brompheniramine Revenue Market Share by Company
3.2.1 Global Brompheniramine Revenue by Company (2018-2020)
3.2.2 Global Brompheniramine Revenue Market Share by Company (2018-2020)
3.3 Global Brompheniramine Sale Price by Company
3.4 Global Brompheniramine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Brompheniramine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Brompheniramine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Brompheniramine by Regions
4.1 Brompheniramine by Regions
4.2 Americas Brompheniramine Consumption Growth
4.3 APAC Brompheniramine Consumption Growth
4.4 Europe Brompheniramine Consumption Growth
4.5 Middle East & Africa Brompheniramine Consumption Growth
5 Americas
5.1 Americas Brompheniramine Consumption by Countries
5.1.1 Americas Brompheniramine Consumption by Countries (2015-2020)
5.1.2 Americas Brompheniramine Value by Countries (2015-2020)
5.2 Americas Brompheniramine Consumption by Type
5.3 Americas Brompheniramine Consumption by Access Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Brompheniramine Consumption by Regions
6.1.1 APAC Brompheniramine Consumption by Regions (2015-2020)
6.1.2 APAC Brompheniramine Value by Regions (2015-2020)
6.2 APAC Brompheniramine Consumption by Type
6.3 APAC Brompheniramine Consumption by Access Channel
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Brompheniramine by Countries
7.1.1 Europe Brompheniramine Consumption by Countries (2015-2020)
7.1.2 Europe Brompheniramine Value by Countries (2015-2020)
7.2 Europe Brompheniramine Consumption by Type
7.3 Europe Brompheniramine Consumption by Access Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Brompheniramine by Countries
8.1.1 Middle East & Africa Brompheniramine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Brompheniramine Value by Countries (2015-2020)
8.2 Middle East & Africa Brompheniramine Consumption by Type
8.3 Middle East & Africa Brompheniramine Consumption by Access Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Brompheniramine Distributors
10.3 Brompheniramine Customer
11 Global Brompheniramine Market Forecast
11.1 Global Brompheniramine Consumption Forecast (2021-2025)
11.2 Global Brompheniramine Forecast by Regions
11.2.1 Global Brompheniramine Forecast by Regions (2021-2025)
11.2.2 Global Brompheniramine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Brompheniramine Forecast by Type
11.8 Global Brompheniramine Forecast by Access Channel
12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Brompheniramine Product Offered
12.1.3 Pfizer Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Endo International
12.2.1 Company Information
12.2.2 Brompheniramine Product Offered
12.2.3 Endo International Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Endo International Latest Developments
12.3 AMAG Pharmaceuticals
12.3.1 Company Information
12.3.2 Brompheniramine Product Offered
12.3.3 AMAG Pharmaceuticals Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 AMAG Pharmaceuticals Latest Developments
12.4 USL Pharma
12.4.1 Company Information
12.4.2 Brompheniramine Product Offered
12.4.3 USL Pharma Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 USL Pharma Latest Developments
12.5 Watson Laboratories
12.5.1 Company Information
12.5.2 Brompheniramine Product Offered
12.5.3 Watson Laboratories Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Watson Laboratories Latest Developments
12.6 PAI
12.6.1 Company Information
12.6.2 Brompheniramine Product Offered
12.6.3 PAI Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 PAI Latest Developments
12.7 Newtron Pharmaceuticals
12.7.1 Company Information
12.7.2 Brompheniramine Product Offered
12.7.3 Newtron Pharmaceuticals Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Newtron Pharmaceuticals Latest Developments
12.8 Teva
12.8.1 Company Information
12.8.2 Brompheniramine Product Offered
12.8.3 Teva Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Teva Latest Developments
12.9 Nexgen Pharma
12.9.1 Company Information
12.9.2 Brompheniramine Product Offered
12.9.3 Nexgen Pharma Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Nexgen Pharma Latest Developments
12.10 Ivax Pharmaceuticals
12.10.1 Company Information
12.10.2 Brompheniramine Product Offered
12.10.3 Ivax Pharmaceuticals Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Ivax Pharmaceuticals Latest Developments
12.11 Novartis
12.11.1 Company Information
12.11.2 Brompheniramine Product Offered
12.11.3 Novartis Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Novartis Latest Developments
12.12 Tanta Pharmaceuticals
12.12.1 Company Information
12.12.2 Brompheniramine Product Offered
12.12.3 Tanta Pharmaceuticals Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Tanta Pharmaceuticals Latest Developments
12.13 Merck
12.13.1 Company Information
12.13.2 Brompheniramine Product Offered
12.13.3 Merck Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Merck Latest Developments
12.14 Eon Pharma
12.14.1 Company Information
12.14.2 Brompheniramine Product Offered
12.14.3 Eon Pharma Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Eon Pharma Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Brompheniramine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Brompheniramine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Brompheniramine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Oral Solution
Table 7. Major Players of Tablet
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Brompheniramine Consumption Market Share by Type (2015-2020)
Table 10. Global Brompheniramine Revenue by Type (2015-2020) ($ million)
Table 11. Global Brompheniramine Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Brompheniramine Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Access Channel (2015-2020)
Table 14. Global Brompheniramine Consumption Market Share by Access Channel (2015-2020)
Table 15. Global Brompheniramine Value by Access Channel (2015-2020)
Table 16. Global Brompheniramine Value Market Share by Access Channel (2015-2020)
Table 17. Global Brompheniramine Sale Price by Access Channel (2015-2020)
Table 18. Global Brompheniramine Sales by Company (2017-2019) (K Units)
Table 19. Global Brompheniramine Sales Market Share by Company (2017-2019)
Table 20. Global Brompheniramine Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Brompheniramine Revenue Market Share by Company (2017-2019)
Table 22. Global Brompheniramine Sale Price by Company (2017-2019)
Table 23. Global Brompheniramine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Brompheniramine Products Offered
Table 25. Brompheniramine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Brompheniramine Consumption by Regions 2015-2020 (K Units)
Table 27. Global Brompheniramine Consumption Market Share by Regions 2015-2020
Table 28. Global Brompheniramine Value by Regions 2015-2020 ($ Millions)
Table 29. Global Brompheniramine Value Market Share by Regions 2015-2020
Table 30. Americas Brompheniramine Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Brompheniramine Consumption Market Share by Countries (2015-2020)
Table 32. Americas Brompheniramine Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Brompheniramine Value Market Share by Countries (2015-2020)
Table 34. Americas Brompheniramine Consumption by Type (2015-2020) (K Units)
Table 35. Americas Brompheniramine Consumption Market Share by Type (2015-2020)
Table 36. Americas Brompheniramine Consumption by Access Channel (2015-2020) (K Units)
Table 37. Americas Brompheniramine Consumption Market Share by Access Channel (2015-2020)
Table 38. APAC Brompheniramine Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Brompheniramine Consumption Market Share by Countries (2015-2020)
Table 40. APAC Brompheniramine Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Brompheniramine Value Market Share by Regions (2015-2020)
Table 42. APAC Brompheniramine Consumption by Type (2015-2020) (K Units)
Table 43. APAC Brompheniramine Consumption Market Share by Type (2015-2020)
Table 44. APAC Brompheniramine Consumption by Access Channel (2015-2020) (K Units)
Table 45. APAC Brompheniramine Consumption Market Share by Access Channel (2015-2020)
Table 46. Europe Brompheniramine Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Brompheniramine Consumption Market Share by Countries (2015-2020)
Table 48. Europe Brompheniramine Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Brompheniramine Value Market Share by Countries (2015-2020)
Table 50. Europe Brompheniramine Consumption by Type (2015-2020) (K Units)
Table 51. Europe Brompheniramine Consumption Market Share by Type (2015-2020)
Table 52. Europe Brompheniramine Consumption by Access Channel (2015-2020) (K Units)
Table 53. Europe Brompheniramine Consumption Market Share by Access Channel (2015-2020)
Table 54. Middle East & Africa Brompheniramine Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Brompheniramine Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Brompheniramine Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Brompheniramine Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Brompheniramine Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Brompheniramine Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Brompheniramine Consumption by Access Channel (2015-2020) (K Units)
Table 61. Middle East & Africa Brompheniramine Consumption Market Share by Access Channel (2015-2020)
Table 62. Brompheniramine Distributors List
Table 63. Brompheniramine Customer List
Table 64. Global Brompheniramine Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Brompheniramine Consumption Market Forecast by Regions
Table 66. Global Brompheniramine Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Brompheniramine Value Market Share Forecast by Regions
Table 68. Global Brompheniramine Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Brompheniramine Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Brompheniramine Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Brompheniramine Value Market Share Forecast by Type (2021-2025)
Table 72. Global Brompheniramine Consumption Forecast by Access Channel (2021-2025) (K Units)
Table 73. Global Brompheniramine Consumption Market Share Forecast by Access Channel (2021-2025)
Table 74. Global Brompheniramine Value Forecast by Access Channel (2021-2025) ($ Millions)
Table 75. Global Brompheniramine Value Market Share Forecast by Access Channel (2021-2025)
Table 76. Pfizer Product Offered
Table 77. Pfizer Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Pfizer Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 81. Endo International Product Offered
Table 82. Endo International Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Endo International Main Business
Table 84. Endo International Latest Developments
Table 85. Endo International Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 86. AMAG Pharmaceuticals Product Offered
Table 87. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. AMAG Pharmaceuticals Main Business
Table 89. AMAG Pharmaceuticals Latest Developments
Table 90. AMAG Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 91. USL Pharma Product Offered
Table 92. USL Pharma Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. USL Pharma Main Business
Table 94. USL Pharma Latest Developments
Table 95. USL Pharma Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 96. Watson Laboratories Product Offered
Table 97. Watson Laboratories Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Watson Laboratories Main Business
Table 99. Watson Laboratories Latest Developments
Table 100. Watson Laboratories Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 101. PAI Product Offered
Table 102. PAI Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. PAI Main Business
Table 104. PAI Latest Developments
Table 105. PAI Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 106. Newtron Pharmaceuticals Product Offered
Table 107. Newtron Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 108. Newtron Pharmaceuticals Main Business
Table 109. Newtron Pharmaceuticals Latest Developments
Table 110. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Teva Product Offered
Table 112. Teva Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Teva Main Business
Table 114. Teva Latest Developments
Table 115. Teva Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 116. Nexgen Pharma Product Offered
Table 117. Nexgen Pharma Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Nexgen Pharma Main Business
Table 119. Nexgen Pharma Latest Developments
Table 120. Nexgen Pharma Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 121. Ivax Pharmaceuticals Product Offered
Table 122. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Ivax Pharmaceuticals Main Business
Table 124. Ivax Pharmaceuticals Latest Developments
Table 125. Ivax Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 126. Novartis Product Offered
Table 127. Novartis Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Novartis Main Business
Table 129. Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Novartis Latest Developments
Table 131. Tanta Pharmaceuticals Product Offered
Table 132. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Tanta Pharmaceuticals Main Business
Table 134. Tanta Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Tanta Pharmaceuticals Latest Developments
Table 136. Merck Product Offered
Table 137. Merck Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. Merck Main Business
Table 139. Merck Latest Developments
Table 140. Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Eon Pharma Product Offered
Table 142. Eon Pharma Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 143. Eon Pharma Main Business
Table 144. Eon Pharma Latest Developments
Table 145. Eon Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Brompheniramine
Figure 2. Brompheniramine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Brompheniramine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Brompheniramine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral Solution
Figure 7. Product Picture of Tablet
Figure 8. Global Brompheniramine Consumption Market Share by Type (2015-2020)
Figure 9. Global Brompheniramine Value Market Share by Type (2015-2020)
Figure 10. Brompheniramine Consumed in Hospital
Figure 11. Global Brompheniramine Market: Hospital (2015-2020) (K Units)
Figure 12. Global Brompheniramine Market: Hospital (2015-2020) ($ Millions)
Figure 13. Brompheniramine Consumed in Drug Store
Figure 14. Global Brompheniramine Market: Drug Store (2015-2020) (K Units)
Figure 15. Global Brompheniramine Market: Drug Store (2015-2020) ($ Millions)
Figure 16. Global Brompheniramine Consumption Market Share by Access Channel (2015-2020)
Figure 17. Global Brompheniramine Value Market Share by Access Channel (2015-2020)
Figure 18. Global Brompheniramine Sales Market Share by Company in 2017
Figure 19. Global Brompheniramine Sales Market Share by Company in 2019
Figure 20. Global Brompheniramine Revenue Market Share by Company in 2017
Figure 21. Global Brompheniramine Revenue Market Share by Company in 2019
Figure 22. Global Brompheniramine Sale Price by Company in 2019
Figure 23. Global Brompheniramine Consumption Market Share by Regions 2015-2020
Figure 24. Global Brompheniramine Value Market Share by Regions 2015-2020
Figure 25. Americas Brompheniramine Consumption 2015-2020 (K Units)
Figure 26. Americas Brompheniramine Value 2015-2020 ($ Millions)
Figure 27. APAC Brompheniramine Consumption 2015-2020 (K Units)
Figure 28. APAC Brompheniramine Value 2015-2020 ($ Millions)
Figure 29. Europe Brompheniramine Consumption 2015-2020 (K Units)
Figure 30. Europe Brompheniramine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Brompheniramine Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Brompheniramine Value 2015-2020 ($ Millions)
Figure 33. Americas Brompheniramine Consumption Market Share by Countries in 2019
Figure 34. Americas Brompheniramine Value Market Share by Countries in 2019
Figure 35. Americas Brompheniramine Consumption Market Share by Type in 2019
Figure 36. Americas Brompheniramine Consumption Market Share by Access Channel in 2019
Figure 37. United States Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 38. United States Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Brompheniramine Consumption Market Share by Countries in 2019
Figure 44. APAC Brompheniramine Value Market Share by Regions in 2019
Figure 45. APAC Brompheniramine Consumption Market Share by Type in 2019
Figure 46. APAC Brompheniramine Consumption Market Share by Access Channel in 2019
Figure 47. China Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 48. China Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 55. India Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 56. India Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Brompheniramine Consumption Market Share by Countries in 2019
Figure 60. Europe Brompheniramine Value Market Share by Countries in 2019
Figure 61. Europe Brompheniramine Consumption Market Share by Type in 2019
Figure 62. Europe Brompheniramine Consumption Market Share by Access Channel in 2019
Figure 63. Germany Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 65. France Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 66. France Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 68. UK Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Brompheniramine Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Brompheniramine Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Brompheniramine Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Brompheniramine Consumption Market Share by Access Channel in 2019
Figure 77. Egypt Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Brompheniramine Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Brompheniramine Value Growth 2015-2020 ($ Millions)
Figure 87. Global Brompheniramine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Brompheniramine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Brompheniramine Consumption 2021-2025 (K Units)
Figure 90. Americas Brompheniramine Value 2021-2025 ($ Millions)
Figure 91. APAC Brompheniramine Consumption 2021-2025 (K Units)
Figure 92. APAC Brompheniramine Value 2021-2025 ($ Millions)
Figure 93. Europe Brompheniramine Consumption 2021-2025 (K Units)
Figure 94. Europe Brompheniramine Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Brompheniramine Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Brompheniramine Value 2021-2025 ($ Millions)
Figure 97. United States Brompheniramine Consumption 2021-2025 (K Units)
Figure 98. United States Brompheniramine Value 2021-2025 ($ Millions)
Figure 99. Canada Brompheniramine Consumption 2021-2025 (K Units)
Figure 100. Canada Brompheniramine Value 2021-2025 ($ Millions)
Figure 101. Mexico Brompheniramine Consumption 2021-2025 (K Units)
Figure 102. Mexico Brompheniramine Value 2021-2025 ($ Millions)
Figure 103. Brazil Brompheniramine Consumption 2021-2025 (K Units)
Figure 104. Brazil Brompheniramine Value 2021-2025 ($ Millions)
Figure 105. China Brompheniramine Consumption 2021-2025 (K Units)
Figure 106. China Brompheniramine Value 2021-2025 ($ Millions)
Figure 107. Japan Brompheniramine Consumption 2021-2025 (K Units)
Figure 108. Japan Brompheniramine Value 2021-2025 ($ Millions)
Figure 109. Korea Brompheniramine Consumption 2021-2025 (K Units)
Figure 110. Korea Brompheniramine Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Brompheniramine Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Brompheniramine Value 2021-2025 ($ Millions)
Figure 113. India Brompheniramine Consumption 2021-2025 (K Units)
Figure 114. India Brompheniramine Value 2021-2025 ($ Millions)
Figure 115. Australia Brompheniramine Consumption 2021-2025 (K Units)
Figure 116. Australia Brompheniramine Value 2021-2025 ($ Millions)
Figure 117. Germany Brompheniramine Consumption 2021-2025 (K Units)
Figure 118. Germany Brompheniramine Value 2021-2025 ($ Millions)
Figure 119. France Brompheniramine Consumption 2021-2025 (K Units)
Figure 120. France Brompheniramine Value 2021-2025 ($ Millions)
Figure 121. UK Brompheniramine Consumption 2021-2025 (K Units)
Figure 122. UK Brompheniramine Value 2021-2025 ($ Millions)
Figure 123. Italy Brompheniramine Consumption 2021-2025 (K Units)
Figure 124. Italy Brompheniramine Value 2021-2025 ($ Millions)
Figure 125. Russia Brompheniramine Consumption 2021-2025 (K Units)
Figure 126. Russia Brompheniramine Value 2021-2025 ($ Millions)
Figure 127. Spain Brompheniramine Consumption 2021-2025 (K Units)
Figure 128. Spain Brompheniramine Value 2021-2025 ($ Millions)
Figure 129. Egypt Brompheniramine Consumption 2021-2025 (K Units)
Figure 130. Egypt Brompheniramine Value 2021-2025 ($ Millions)
Figure 131. South Africa Brompheniramine Consumption 2021-2025 (K Units)
Figure 132. South Africa Brompheniramine Value 2021-2025 ($ Millions)
Figure 133. Israel Brompheniramine Consumption 2021-2025 (K Units)
Figure 134. Israel Brompheniramine Value 2021-2025 ($ Millions)
Figure 135. Turkey Brompheniramine Consumption 2021-2025 (K Units)
Figure 136. Turkey Brompheniramine Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Brompheniramine Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Brompheniramine Value 2021-2025 ($ Millions)
Figure 139. Pfizer Brompheniramine Market Share (2018-2020)
Figure 140. Endo International Brompheniramine Market Share (2018-2020)
Figure 141. AMAG Pharmaceuticals Brompheniramine Market Share (2018-2020)
Figure 142. USL Pharma Brompheniramine Market Share (2018-2020)
Figure 143. Watson Laboratories Brompheniramine Market Share (2018-2020)
Figure 144. PAI Brompheniramine Market Share (2018-2020)
Figure 145. Newtron Pharmaceuticals Brompheniramine Market Share (2018-2020)
Figure 146. Teva Brompheniramine Market Share (2018-2020)
Figure 147. Nexgen Pharma Brompheniramine Market Share (2018-2020)
Figure 148. Ivax Pharmaceuticals Brompheniramine Market Share (2018-2020)
Figure 149. Novartis Brompheniramine Market Share (2018-2020)
Figure 150. Tanta Pharmaceuticals Brompheniramine Market Share (2018-2020)
Figure 151. Merck Brompheniramine Market Share (2018-2020)
Figure 152. Eon Pharma Brompheniramine Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets